Document Detail


Treatment of hemoptysis in patients with cavitary aspergilloma of the lung: value of percutaneous instillation of amphotericin B.
MedLine Citation:
PMID:  8372746     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Surgery has been the primary choice of treatment for cavitary aspergillomas of the lung, but it is associated with relatively high morbidity and mortality. The effectiveness of percutaneous intracavitary instillation of an antifungal agent in seven patients with hemoptysis caused by cavitary aspergilloma was evaluated. SUBJECTS AND METHODS: All patients had hemoptysis associated with a cavitary pulmonary aspergilloma. In four patients who had aspergillomas without lung interposed between the cavity and the chest wall, 50 mg of amphotericin B in 10 ml of 5% dextrose in water and then 8 mg of bromhexine (a mucolytic agent) mixed with 10 ml of normal saline were instilled into the cavity through an 8-French catheter daily for 15 days. In three patients who had lung interposed between the cavity and the chest wall, the treatment was administered twice at 3-day intervals through a 20-gauge needle. The presence or absence of hemoptysis was recorded after each instillation of amphotericin B, and the size of aspergilloma was assessed with follow-up radiographs. RESULTS: Hemoptysis ceased within 5 days after instillation of amphotericin B in all patients. In the four patients treated through a catheter, the aspergillomas resolved completely in three patients and resolved partially in one. In the three patients treated through a fine needle, the aspergillomas resolved partially. Mild hemoptysis during the procedure, a small pneumothorax, and subcutaneous emphysema occurred in one patient each. CONCLUSION: Our results suggest that percutaneous intracavitary instillation of amphotericin B is a safe and effective method of treating hemoptysis caused by aspergillomas.
Authors:
K S Lee; H T Kim; Y H Kim; K O Choe
Related Documents :
20805736 - Analysis of seed loss and pulmonary seed migration in patients treated with virtual nee...
3979136 - Fiberoptic bronchoscopy in the evaluation of lung abscesses.
16685016 - The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleur...
19960786 - Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemi...
3279086 - Iontophoretic study of skin vessel reactivity in atopic dermatitis and its correlation ...
19420176 - Chronic brucellosis and persistence of brucella melitensis dna.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  AJR. American journal of roentgenology     Volume:  161     ISSN:  0361-803X     ISO Abbreviation:  AJR Am J Roentgenol     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1993-10-12     Completed Date:  1993-10-12     Revised Date:  2010-03-24    
Medline Journal Info:
Nlm Unique ID:  7708173     Medline TA:  AJR Am J Roentgenol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  727-31     Citation Subset:  AIM; IM    
Affiliation:
Department of Radiology, College of Medicine, Soonchunhyang University, Bongmyung-Dong, Chunan, Korea.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amphotericin B / administration & dosage*
Aspergillosis / complications,  drug therapy*,  radiography
Female
Hemoptysis / etiology*,  therapy
Humans
Instillation, Drug
Lung Diseases, Fungal / complications,  drug therapy*,  radiography
Male
Middle Aged
Radiography, Interventional
Recurrence
Chemical
Reg. No./Substance:
1397-89-3/Amphotericin B

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cause of regional ventilation-perfusion mismatching in patients with idiopathic pulmonary fibrosis: ...
Next Document:  Pulmonary infections caused by Mycobacterium malmoense and Mycobacterium tuberculosis: comparison of...